GPCR
Structure Therapeutics Inc - ADR

1,960
Mkt Cap
$4.05B
Volume
3.71M
52W High
$94.90
52W Low
$13.22
PE Ratio
-18.27
GPCR Fundamentals
Price
$69.09
Prev Close
$66.74
Open
$67.00
50D MA
$32.93
Beta
1.01
Avg. Volume
1.25M
EPS (Annual)
-$2.33
P/B
5.26
Rev/Employee
$0.00
Loading...
Loading...
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
163

Frequently Asked Questions

What is Market Cap of Structure Therapeutics Inc - ADR?
What is the 52-week high for Structure Therapeutics Inc - ADR?
What is the 52-week low for Structure Therapeutics Inc - ADR?
What is Structure Therapeutics Inc - ADR stock price today?
What was Structure Therapeutics Inc - ADR stock price yesterday?
What is the PE ratio of Structure Therapeutics Inc - ADR?
What is the Price-to-Book ratio of Structure Therapeutics Inc - ADR?
What is the 50-day moving average of Structure Therapeutics Inc - ADR?
How many employess does Structure Therapeutics Inc - ADR has?

Latest GPCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.